VYRSA TECHNOLOGIES
SI Joint Fusion with VYRSA™pro
A simple, one time procedure providing patients with SI joint dysfunction a minimally invasive solution to combat pain. After a thorough diagnostic process, physicians can help alleviate, and in many cases eliminate, chronic pain by delivering a single implant into the SI joint.
Through one small incision, a VYRSA™-trained physician can deliver an implant into the SI Joint to immediately restore stability and create an ideal environment for long term fusion.
source: vyrsatech.com
source: vyrsatech.com
source: vyrsatech.com
VYRSA TECHNOLOGIES
SI Joint Fusion with VYRSA V1™
VYRSA V1™ is the first and only posterior sacroiliac joint fusion implant offering self-contained lateral transfixation for immediate stability.
The V1™ Implant is an FDA 510k-cleared device intended to transfix the sacroiliac (SI) joint for immediate stability and long term fusion. The mechanism of stabilization consists of titanium anchors deployed laterally through the ilium, across the sacroiliac joint and into the sacrum. This device has been proven to substantially reduce SI joint motion through comprehensive biomechanics testing performed in collaboration with the FDA*.
source: vyrsatech.com
source: vyrsatech.com
source: vyrsatech.com
OUR TRUSTED PARTNER
VYRSA is committed to the continuous development of innovative technologies for SI joint pain. Each system is developed based on the following principles.
- Leveraging known principles of arthrodesis honed by surgeons across decades to create the best possible implant designs.
- Pushing toward less invasive solutions that reduce complications, operative time, and patient recovery.
- Collection of data to establish product benefits and create better-informed stakeholders.
- Patient and provider advocacy to expand and maintain access to innovative therapies.
